Astex Pharmaceuticals, Inc. (US)
Michelle Fung is currently serving as the Senior Study Manager at Taiho Oncology, Inc. with previous experience in various clinical trial and research positions at Astex Pharmaceuticals, Inc., Mendel Biotechnology, Inc., and University of California, San Diego. Michelle holds a Master's degree in Biology from UC San Diego and a Certification in Clinical Research Conduct and Management from University of California, Berkeley Extension.
Astex Pharmaceuticals, Inc. (US)
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies. Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc. Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.